title: The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
abstract: The significance of CEA, CA19-9 and CA72-4 was evaluated the for early detection of disease recurrence, on the basis of retrospective evaluation of routine data in patients with colorectal carcinoma. They also considered the dependence of the results of these data analyses on the definition of groups of patients, both with no evidence of disease (NED) and with recurrence of disease (RD).
  
  
  METHODS
  From January 1994 to March 1999 serum levels of CEA, CA19-9 and CA72-4 were determined in the follow-up of 517 patients with colorectal cancer and compared with the retrospectively confirmed clinical status of the patients.
  
  
  RESULTS
  CEA and CA19-9 showed comparable sensitivities in the detection of locoregional recurrence of colorectal carcinoma, whilst the sensitivity of CA72-4 was considerably lower. CEA is an optimal marker for detecting distant metastases, in particular liver metastases, since its sensitivity considerably exceeds the sensitivities of the other two monitored markers.
  
  
  CONCLUSIONS
  Using routine data required detailed analysis and clear definitions of groups of patients with NED and RD. The following conclusions for the evaluation of data were drawn from this analysis: a) Tumor marker cut-off values and sensitivities related to 95% specificity of remission values depended strongly on the given definition of the groups of patients with NED and RD. b) The patient group with NED is best characterized as the group of patients who never developed progression and where all the values which were assessed within a period shorter than six months from the end of therapy and follow-up, or less than six months before progression, death, or before the last marker assessment in the patient, were excluded. c) For the optimal characterisation of the group of patients with RD it is recommended only to consider values obtained during the first progression, after the period of complete post-operative or post-therapeutic remission. d) These conclusions refer not only to routine data, where this correction represents a condition for reliable evaluation, but also to any research done, since they ensure complete homogeneity of the group and mutual comparability of the results.
authors.affiliation: 2nd Dept. of Internal Medicine, Clarles University Hospital, E. Benese 13, 30599 Pilsen, Czech Republic.
authors.forename: L
authors.initials: L
authors.lastname: Holubec
authors.forename: O
authors.initials: O
authors.lastname: Topolcan
authors.forename: R
authors.initials: R
authors.lastname: Pikner
authors.forename: L
authors.initials: L
authors.lastname: Pecen
authors.forename: J
authors.initials: J
authors.lastname: Vaclavickova
authors.forename: M
authors.initials: M
authors.lastname: Wirthova
authors.forename: J
authors.initials: J
authors.lastname: Molacek
authors.forename: P
authors.initials: P
authors.lastname: Stieber
authors.forename: S
authors.initials: S
authors.lastname: Holdenrieder
authors.forename: L H
authors.initials: LH
authors.lastname: Sen
authors.forename: J
authors.initials: J
authors.lastname: Finek
mesh_terms: D000368:Aged; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D018395:CA-19-9 Antigen / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000378:metabolism; D011379:Prognosis
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; C083825:CA-72-4 antigen; D002272:Carcinoembryonic Antigen